Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 793-804 of 4,306
Drug study icon
CompletedNCT00929955

Role of Anti-Inflammatory Agents in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Karachi
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Schizophrenia
Drug study icon
CompletedNCT01999309

Simvastatin Addition for people with Recent-onset Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Groningen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
Netherlands
Sponsor
Iris Sommer
Condition
Schizophrenia
Device study icon
CompletedNCT03701100

The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Taipei
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 20 Years to 65 Years
Countries
Taiwan
Sponsor
Tri-Service General Hospital (TSGH)
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN23256704

A study to understand how immune function affects symptoms of psychosis

This observational study is following people with Psychosis or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Bristol
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN10334895

Cannabidiol for patients at a high-risk of psychosis

This study is testing a medication approach for people with Clinical high-risk for psychosis, Mental and Behavioural Disorders, or Clinical high-risk state for psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United Kingdom
Sponsor
King’s College London and South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN37176025

Investigating the use of clozapine in young people with psychosis

This observational study is following people with Treatment-resistant psychosis or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 12 Years to 24 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.